Evidence map›Paper›PMID 35259817›Full record

ReviewNeural regeneration research2022

Graphene and graphene-based materials in axonal repair of spinal cord injury.

Shi-Xin Wang, Yu-Bao Lu, Xue-Xi Wang, Yan Wang, Yu-Jun Song, Xiao Wang, Munkhtuya Nyamgerelt

Open access · goldAbstract readReview
In one paragraph

Review in Neural regeneration research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Recent Advances in the Treatment of Spinal Cord Injury.The archives of bone and joint surgery · 2024
    Review
  15. Review
  16. Article
  17. Spinal cord injury: molecular mechanisms and therapeutic interventions.Signal transduction and targeted therapy · 2023
    Review
  18. Review
  19. The Application of Biomaterials in Spinal Cord Injury.International journal of molecular sciences · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shi-Xin WangSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu Province, China.
Yu-Bao LuThe Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu Province; Department of Spine Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
Xue-Xi WangSchool of Basic Medical Sciences, Lanzhou University; Key Laboratory of Evidence-Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, Gansu Province, China.
Yan WangSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu Province, China.
Yu-Jun SongSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu Province, China.
Xiao WangSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu Province, China.
Munkhtuya NyamgereltSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu Province, China.
Lanzhou University · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene and graphene-based materials have the ability to induce stem cells to differentiate into neurons, which is necessary to overcome the current problems faced in the clinical treatment of spinal cord injury. This review summarizes the advantages of graphene and graphene-based materials (in particular, composite materials) in axonal repair after spinal cord injury. These materials have good histocompatibility, and mechanical and adsorption properties that can be targeted to improve the environment of axonal regeneration. They also have good conductivity, which allows them to make full use of electrical nerve signal stimulation in spinal cord tissue to promote axonal regeneration. Furthermore, they can be used as carriers of seed cells, trophic factors, and drugs in nerve tissue engineering scaffolds to provide a basis for constructing a local microenvironment after spinal cord injury. However, to achieve clinical adoption of graphene and graphene-based materials for the repair of spinal cord injury, further research is needed to reduce their toxicity.

Indexed as

axonal regenerationgraphenegraphene oxidenerve axon regenerationreduced graphene oxidespinal cord contusionsspinal cord injuryspinal cord trauma

Identifiers

PMID35259817
PMCPMC9083163
OpenAlexW4220837247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.